Do you have Crohn's disease? You may be eligible for a new study.

The VICTRIVA study is a clinical study for adults living with Crohn’s disease. This study is evaluating an investigational therapy for potential use in treating Crohn’s. The investigational therapy being evaluated is a combination of two medications. This is known as a dual targeted therapy

The purpose of the VICTRIVA study is to help researchers learn about the effectiveness of the two study drugs working together and about the safety of this potential therapy option. 

This study is being conducted by Takeda.

You may qualify for the VICTRIVA study if you:

• Are 18 to 65 years of age
• Have been diagnosed with Crohn’s disease for at least 3 months AND your Crohn’s is at least moderately active
• Have tried treatments that did not work well for you or stopped working OR you are not able to tolerate the treatments

You will also need to meet additional requirements. The study doctor will explain these to you.

Talk with your doctor about the VICTRIVA study. They can help you decide if the study may be right for you.

For more information about this study and eligibility requirements contact Allison Everett, lead clinical research coordinator, at 206-745-9845 or email dhiresearch@providence.org. 

About Providence Swedish 

Providence Swedish has served the Puget Sound region since the first Providence hospital opened in Seattle in 1877 and the first Swedish hospital opened in 1910. The two organizations affiliated in 2012 and today comprise the largest health care delivery system in Western Washington, with 24,000 caregivers, eight hospitals and 244 clinics throughout Western Washington – from Everett to Centralia. A not-for-profit family of organizations, Providence Swedish provides more than $545 million in community benefit in the Puget Sound region each year. The health system offers a comprehensive range of services and specialty and subspecialty care in a number of clinical areas, including cancer, cardiovascular health, neurosciences, orthopedics, digestive health and women’s and children’s care. For more information, visit providence.org/swedish.